Mass spectrometry (MS)-based shotgun proteomics allows protein identi fi cations even in complex biological samples. Protein abundances can then be estimated from the counts of MS/MS spectra attributable to each protein, provided that one corrects for differential MS-detectability of the contributing peptides. We describe the use of a method, APEX, which calculates Absolute Protein EXpression levels based on learned correction factors, MS/MS spectral counts, and each protein's probability of correct identi fi cation.
Mass spectrometry (MS) based shotgun proteomics is a fast and relatively easy method for large-scale protein identi fi cation. A typical shotgun proteomics experiment proceeds by tandem MS (MS/MS) analysis of peptides from proteolytically digested proteins, followed by in silico matching of the observed MS/MS spectra against a database of theoretical peptide spectra derived from the expected protein sequences. Typical database search engines include SEQUEST or MASCOT ( see also Chapter 28 ) . Proteins are identi fi ed through combined evidence for their contributing peptides, resulting in a list in which each protein is associated with a con fi dence score (or probability) of correct identi fi cation, e.g., from ProteinProphet ( 1 ) . In addition, an MS dataset provides information on the types and number of different peptide spectra associated with each protein, as well as peak heights corresponding to ion intensities.
A number of approaches have been developed to quantify protein observations from peak heights in shotgun proteomics experiments by introducing internal reference standards, often by addition of isotopically labeled peptides ( 2, 3 ) (for summary see Chapter 7 ). These reference standards can be derived from cells grown in labeled medium, as in SILAC ( 4 ) ( see Chapters 13 and 14 ) , by derivatizing natural samples, as in ICAT ( 5 ) , or can instead be synthesized and added to samples, as in isotope dilution (e.g., AQUA ( 6 ) ) ( see Chapter 17 ) . The necessity (and expense) of synthesizing thousands of isotopically labeled peptides has prevented easy scaling to full proteomes, even when employing unlabeled peptides ( 7 ) .
Thus, development of label-free quantitation methods for mass spectrometry has been of high interest. Peak intensities have been used to estimate protein concentrations, e.g., through average the intensities of contributing peptides ( 8, 9 ) ( see Chapter 16 ) . Other approaches have considered quantitation from the MS/MS sampling statistics in a shotgun proteomics experiment ( see Chapter 22 ) . Both the coverage of unique peptides in a protein (i.e., percentage of possible peptides per protein actually observed) and the total number of repeat observations of MS/MS spectra from all peptides in a protein (spectral count) approximate protein abundance (10) (11) (12) (13) (14) (15) (16) (17) . However, both measures have shortcomings, such as coverage showing saturation (at 100%), spectral counts not accounting for protein size (larger proteins contribute more peptides), both approaches ignoring sampling depth, i.e., the total number of MS/ MS experiments that go into the calculation, and neither approach considering the prior odds of observing any particular peptide in the experiment, i.e., the MS-detectability. Peptides vary considerably in their ability to be detected by an MS instrument due to, for example, chemical sequence properties that affect peptide ionization ( 18 ) . Although such trends can be partly predicted from a 1. Introduction 1 . Mass spectrometry data of peptides. Raw data needs to be postprocessed using MS analysis software of choice (see below). For model training (Subheading 3.2.1 ), a well-de fi ned MS dataset is necessary for which several proteins are con fi dently identi fi ed (or known to be present). 
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protein expression (Fig. 1 ) . The statistical test ( Z -score) is based only on spectral counts; for an estimate of expression fold change between the two samples, APEX expression values need to be calculated as described in Subheading 3.3 .
We describe this protocol with the example of yeast cell lysate analyzed on the LTQ-Orbitrap Classic (Thermo). Additional information may also be obtained from ref. 39 . On the APEX Web site ( http://www.marcottelab.org/APEX_Protocol/ ), we provide input and output fi les created during the process, a suite of corresponding Perl scripts, as well as data for analysis. [Squared brackets] in this text mention Perl scripts corresponding to the described step in the analysis. We also provide example data for training and prediction of MS detectability of E. coli , P. aeruginosa , yeast, rice, mouse, and human proteins both for the LTQ-Orbitrap and/or an LCQ Deca Plus, as well as a Z -score analysis of yeast grown in minimal and rich media. The models trained on these (or other) datasets can analyze data of any origin if the same parameters have been used for data postprocessing. In our example analysis, we train prediction of peptide MS detectability on a set of 89 yeast proteins which are well-observed in an LTQ-Orbitrap MS/MS experiment, and then estimate O i values for all proteins in the entire yeast genome. As an example, the TFC3 protein (YAL001C) has ~500 theoretical peptides from a tryptic digest with £ 2 missed cleavages. Only four different peptides are observed in the given MS/MS dataset with a total of fi ve spectral counts (Fig. 2 ) . Given the sequence properties of all ~500 contributing peptides and a trained model, TFC3's O i value is 60.24, i.e., about 60 peptides are expected for this protein to be observed in an LC-MS/MS analysis on an LTQ-Orbitrap. With an average of 4,000 molecules/protein and a total of 2,033 proteins detected in total, the APEX value for TFC3 is estimated to be ~110 molecules/cell.
1.
If not already done so, postprocess MS/MS raw data with software of choice (e.g., Sequest or Mascot, and PeptideProphet ( 37 ) /ProteinProphet ( 1 ) ) and parse for proteins of con fi dent identi fi cation (e.g., false discovery rate <5%). The fi nal output lists should be available in the .xml and -prot.xml fi le format to be parseable with our Perl scripts [np_parse_ProteinProphet.pl].
2. From these proteins, select a set of ~30-150 proteins identi fi ed at high con fi dence ( see Note 1 ) . Even for these well-identi fi ed proteins, not all theoretically possible peptides will be observed. A comparison of the sequence properties of the observed versus the nonobserved peptides mapping to these proteins is used for training of the computational model (Fig. 2a ) .
3. Digest the amino acid sequences for the proteins in silico into (tryptic) peptides, for example using Proteogest ( 40 ) at http:// www.utoronto.ca/emililab/proteogest.htm . Trypsin cleaves after lysine (K) or arginine (R) unless they are followed by proline (P) (Fig. 2b ) . In silico digestions usually account for 0, 1, or 2 missed cleavages per peptide. Missed cleavages strongly increase the number and types of peptides per protein, i.e., they impact the respective O i value. In our example, we include up to 2 missed cleavages; however, we observe zero missed cleavages for most peptides, i.e., the tryptic digest appears to be nearly complete. If only one or zero missed cleavages are to be allowed, the model should be rebuilt accordingly. For model building, it is suf fi cient to digest only the proteins in the training dataset; however, we typically digest the whole proteome and then select the respective training proteins (see APEX Web site for Perl scripts). The choice of the maximum allowed number of missed tryptic cleavages should be the same for training, testing and application of APEX. The fi le format does not contain peptide identi fi ers; they need to be stored separately. Note that they could be kept in the fi le, but would have to be unselected in the WEKA explorer prior to training.
7. Create a model of peptide MS detectability using WEKA ( see Notes 4, 6 ) . The process requires a lot of computer memory (depending on the size of the training set), thus we recommend allocating extra memory to WEKA when opening it or using the command line options. Here, we describe the steps to be taken with WEKA Explorer Java user interface. To open WEKA and allocate 500 MB memory, enter "java -Xmx512m -jar < your directory here>/weka.jar." Computing times quoted here are obtained allocating 1,800 MB of memory to WEKA with no other processes running.
8. In WEKA, load the .arff fi le in the "Preprocess" tab ( Fig. 3a ) and then switch to "Classify" (Fig. 3b ) . Select classi fi ers in the "Classi fi er-Choose" option: fi rst select CostSensitiveClassi fi er under "meta" classi fi ers. Then, select in the popup window bagging under "meta" classi fi ers. Click on the text bar listing Bagging and select RandomForest under "meta" classi fi ers. Of course, one can chose not to use Bagging or to use a different classi fi er. However, in our experience this performs best. Within the popup window for the CostSensitiveClassi fi er, de fi ne a "costMatrix" ( see Note 3 ). Cost-sensitive training is crucial as the training dataset is heavily biased towards one class (e.g., here 91% of nonobserved peptides) and a cost matrix counteracts this bias by weighted use of the training data. Adjust the matrix size to 2. In our example, the cost matrix looks like as follows: It implies that during learning, the contribution of truepositives, i.e., observed peptides, is weighted as 91% while they represent only 9% of the data. Vice versa, true-negatives, i.e., nonobserved peptides, represent 91% of the data and are down-weighted in their contribution. The cost matrix can also be saved and uploaded in later uses. Specify 10 in the Cross-Validation tab for tenfold cross-validation. 9 . Start calculations by clicking on "Start." Depending on computer power and dataset size, model building with cross-validation takes several minutes.
10. The output fi le contains information on the success of the training (Fig. 3c ) . For example, the F -measure which is the weighted harmonic mean of precision and recall [2 × precision × recall / ( precision + recall )] of class prediction. The closer the F -measure is to 1, the larger are the precision and recall and the better is the prediction. In many training sets, most peptides are not observed; prediction of peptide observation is harder than prediction of nonobservation. Therefore, we recommend paying special attention to the F -measure (as well as precision, recall) of observed peptides (class 1); the larger this F -measure, the better is the model. The F -measure should be >0.5.
In the yeast example, observed peptides (class 1) are predicted with an F -measure of 0.61, i.e., with precision and recall of 0.59 and 0.63, respectively. Nonobserved peptides (class 0) are predicted with much higher precision (0.96) and recall (0.96), and the F -measure is 0.96.
11. Once the training is fi nished and a quality model has been created (see Note 8) , save the model as a .model fi le by rightclicking in the "Results list" section and selecting "Save model." Subheading 3.2.1 can be omitted if a model has been built and saved in previous calculations for a particular MS instrument and setup ( see Notes 7 , 9 , and 10 ). We found that models are similar between MS instruments using the same ionization method and mass range, and the resulting O i values correlate strongly. However, since, for example, an LCQ is less sensitive than an LTQ-Orbitrap, O i values are generally smaller on the former instrument than on the latter.
1. Postprocess MS/MS raw data as in Subheading 2.1 , item 1 (Fig. 2a ) to obtain -prot.xml fi les. This time include all proteins of interest, e.g., with <5% false discovery rate. Parse the fi le to obtain a tab-delimited text fi le [np_parse_ProteinProphet.pl].
2. Digest the amino acid sequences for all proteins of interest (above) in silico into (tryptic) peptides, using the same parameters as in Subheading 3.2.1 , step 3 , i.e., allow for the same number of missed cleavages. Beware that this fi le easily becomes large; a yeast genome with ~6,000 genes in silico digests into ~921,000 peptides ( £ 2 missed cleavages). At the end of each feature vector, place a question mark "?" instead of the "1" or "0" describing peptide observation (Fig. 2b ) .
5. Predict probability of observation (peptide MS detectability) using WEKA. In the "Preprocess" tab, load the .arff fi le created in step 4 . In the "Classify" tab, load the model created in Subheading 3. 7. Cut and paste the output fi le into a text fi le or save it by rightclicking in the "Result list" section and selecting "Save result buffer." The second but last column of the output fi le provides the probability of peptide observation (Fig. 3d ) , i.e., the class 1 probability, and this value is used for further calculations. Note that while peptide MS detectability is binary during training ( observed / nonobserved ), it is continuous when calculating O i (class 1 probability: value between 0 and 1). ( 26, 27, 29 ) , for E. coli < 1,000 ( 26, 41, 42 ) . In our example experiment, 2,033 proteins were identi fi ed with <5% false discovery rate on the LTQ-Orbitrap; thus, we estimate C = 2,033 proteins × 4,000 molecules/protein » 8.1 × 10 6 molecules. Third, if not cellular lysates but a synthetic protein mixture is used, C can be estimated using the total concentration of proteins in the sample (if known). Fourth, C can also be set to a constant (e.g., 1 or 100) which results in APEX values of proteins relative to each other in the sample. Note that this use of the term relative differs from that in Subheading 3.4 which considers a protein's abundance in two different samples.
4. Calculate APEX protein absolute protein expression values using Eq. 1 [np_APEX_from_Oi_and_protlist.pl].
In Eq. 1 , n i is the total spectral count for protein i (total number of MS/MS spectra attributable to protein i), O i is the expected unique peptide count for protein i (sum of peptide MS detectabilities for a given protein), and p i is the protein identi fi cation probability. Values for n i and p i are extracted from postprocessed MS/MS data; O i is computed as described above.
As a control for correct APEX calculations, we that recommend the user conducts a spike-in experiment as described in the original publication ( 26 ) . In such an experiment, a mixture of
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proteins of known abundances is spiked into cellular lysate and APEX is used to estimate protein concentrations in the mixture. This control experiment may be conducted once in the lab to assure that the setup produces reliable estimates of protein concentrations. It does not have to be repeated frequently. 3. Calculate the total number of observed MS/MS spectra (total spectral counts) N for each sample. This sum includes only peptides of con fi dent identi fi cation (above threshold). Convert the spectral counts n i into fractions fi = n i / N .
4. Calculate for each protein the overall proportion fi ,0 = ( n i,1 + n i,2 )/ ( N 1 + N 2 ). The proportion fi ,0 is the null expectation in the event that protein i is present at the same level in both samples. The calculation can be done for proteins which are con fi dently identi fi ed in both samples, and for proteins which are only identi fi ed in one sample but assumed to be absent in the other sample.
5. Calculate for each protein a Z -score of differential expression according to
where N 1 and N 2 are the total spectral counts in samples 1 and 2, fi ,0 is the overall proportion of a protein's spectral counts, and fi ,1 and fi ,2 are the proportions of a protein's spectral counts in sample 1 and 2, respectively. Note that script [np_two_ fi les_ Zscore.pl] performs steps 3 -5 and provides Z -scores as the output of a comparison of two .apex fi les.
Two-sided P -values require |Z| > 1.96 for P -value < 0.05; |Z| > 2.58 for P -value < 0.01. Proteins of high abundance in both samples can be signi fi cantly differentially expressed even if the actual expression fold-change is small. Thus, we recommend examining High-quality training data is crucial for successful model building and model performance. The training set of proteins (and its size) should be chosen so that (1) recall and precision ( F -measure) in cross-validation are maximized ( see Subheading 3.2 , step 10 ); and (2) time for model calculation is within desired time frame. In general, the larger the fraction of observed versus nonobserved peptides in the data (i.e., the larger the number of true-positives compared to true-negatives), the better is the model performance. This fraction seems more important than the actual number of proteins (or peptides) selected to be in the training dataset (~30-150). However, the larger the training dataset, the more time is required to build a model. We usually select a training dataset based on high protein identi fi cation probabilities as well as high spectral counts per protein from a trusted dataset. The protein identi fi cation probabilities are an output from the ProteinProphet ( 1 ) software. If the user decides not to use Peptide-and ProteinProphet, training proteins could be selected based on high scores obtained in the primary database search (with SEQUEST, MASCOT, or similar) ( see Chapter 28 ) . Alternatively, training proteins could be chosen based on knowledge of their presence in other data (e.g., from Western blot experiments or if using a synthetic mixture). In other words, as long as the user is con fi dent that a certain set of proteins is present in the sample, he or she can compare their observed peptides to their nonobserved peptides and learn MS-detectability from these. For our setup, we found that ion suppression does not seem to play a big role, as the complexity of the mixture (i.e., how many proteins are contained in it) only marginally affects the O i values.
Usually, we obtained the best model when selecting proteins based on high protein identi fi cation probability (e.g., 1.00) and high spectral counts per protein (e.g., >200)-rather than when selecting for high probabilities/spectral counts per peptide. However, note that these cutoffs are MS/MS dataset-and machine-dependent and should be reevaluated for different experimental setups. Our cutoffs provide a guideline for experimentation.
For example, when creating a training fi le for model for data collected on a Thermo LTQ-Orbitrap, we analyzed yeast cellular lysate identifying 89 proteins of high protein identi fi cation probability ( p i = 1.00) and with least 200 total spectral counts per protein. For these proteins, 9% (1,331) of the peptides were observed in the MS/MS experiment; 91% (13,279) of peptides were not observed.
2. The number and types of attributes included is important for model performance.
We observed the best model performance when including a total of 66 attributes (Table 1 ). These length, molecular weight, relative and absolute amino acid frequencies, secondary structure, fi ve attributes identi fi ed by Mallick et al. ( 24 ) and four additional attributes. As described by Mallick et al. ( 24 ) , different instruments, in particular different ionization 1 , step 2 ) . Alternatively, use the command-line to set up WEKA runs, avoiding the memory-consuming Java-based interface. When applying the model to predict peptide MS detectability, we found that for a test fi le with 100,000 lines, at least 1,500 MB memory is required ( see Subheading 3. 2.1 , step 7 ) . If the test fi le contains more than 100,000 lines, we recommend splitting the fi le into smaller .arff fi les, assigning more memory when starting WEKA ( see Subheading 3.2.1 , step 7 ) and/or using the WEKA command line interface. For example, the peptide fi le for the whole yeast genome needs to be split into approximately ten separate .arff fi les with each 100,000 lines or fewer. Unselect "Output model" under "More options" to save the memory required to output the model.
5. An error message appears when uploading the .arff training or testing fi le. Thoroughly check the .arff fi le format. Check that the number of attributes listed in the header is the same as the number of attributes (features) in the data rows. Ensure that all rows with data entries have the same number of attributes listed. Check for correct description of attribute types, e.g., as string , numeric or class . Very that rows lack peptide names or other identi fi ers. If nothing helps, try uploading our example .arff fi les and work from there.
6. Training results in a poor model, e.g., the F -measure for observed peptides is <0.5. Check that the correct cost matrix is used, as described in Subheading 3.2.1 , step 8 . Check quality of the training data ( see Note 1 ). Consider reducing your training set to fewer proteins, possibly hand-select them for their quality of peptide identi fi cation. Check that peptides classi fi ed as observed have high peptide identi fi cation scores (or probabilities). Check that proteins in the training set are not degenerate, i.e., that several proteins of different names do not map to the same group of peptides. Check that peptides in the training set are not degenerate, i.e., that their observation is not mapped to several proteins of different names.
(When selecting our training data, we exclude all degenerate proteins and peptides.) Ensure you use WEKA correctly by training on one of the fi les provided on the APEX Web site and comparing your training outputs with our result fi les. Check types of peptide attributes ( see Note 2 ) . Modify the kinds and number of attributes used to describe peptide sequences. Not all 66 attributes used in our example set are equally important for training. Performing different tests in the "Attribute selection" section in WEKA (Ranker-PrincipalComponents, Ranker-InfoGain, and BestFirst-CfsSubset), we identi fi ed attributes describing peptide length, the isoelectric point, hydrophobicity, solvent access, solubility, volume, secondary structure as most important, while among amino acid frequencies the number of C, R, and K were top-ranked (see APEX Web site). Consider adding attributes listed by Mallick et al. ( 24 ) 9. When to retrain the model. A number of additional options are worth keeping in mind. Some users may prefer to retrain the O i -values for each organism they use, assuming that organism-speci fi c properties (e.g., amino acid composition, the extent of posttranslational modi fi cations) may in fl uence the overall MS-detectability of the peptides. Other users even consider retraining for every experiment. In principle, the O i -values are robust when similar experimental conditions apply. While a model built on one organism's data might be usable to predict MS-detectability for another other organism, mammalian proteins may, for example, be more heavily phosphorylated than bacterial proteins, and phosphorylation impacts MS-detectability of peptides containing serine, threonine, or tyrosine. In this case, retraining with a mammalian dataset to be used to predict mammalian APEX values is reasonable. The user should, however, retrain the Oi-values if the mass spectrometry equipment or protocols change. For example, different MS instruments, and in particular different ionization techniques strongly in fl uence MS detectability. Experimental conditions such as oxidization of cysteine residues using iodoacetamide also in fl uence MS detectability of cysteine containing peptides.
10. Future possible re fi nements.
We provide this protocol not only for easy calculation of absolute and relative protein expression values but also encourage the reader to experiment and optimize the method to suit his or her needs. Several re fi nements are possible. For example, when training for peptide MS detectability, actual peptide identi fi cation probabilities could be taken into account: instead of using a binary classi fi cation ( observed , nonobserved ) one would use a continuous value. Peptide charge states and prior modi fi cations (e.g., on Cysteine residues) may also be considered. Further, the user may try and estimate how the number of missed cleavages may affect the total number of peptides observed, and incorporate that into the calculation. In addition to charge state, more complex features such as bi-amino acid frequencies may be included in the training process; however, the user should be careful to avoid over fi tting, i.e., to have disproportionally many features compared to the size of the dataset. When including more features, the user should keep two aspects in mind. First, ideally the feature values show a moundshaped frequency distribution which is easy to check in WEKA. If the distribution is far from Gaussian, one should consider (log) transforming the values to achieve a better distribution. Many learning algorithms require normally distributed feature values. Second, if two features are highly intercorrelated (e.g., Spearman's R > 0.9), for example sequence length and molecular weight, one of the features should be left out to reduce redundancy.
Further information and tools.
For APEX calculations, the primary publication ( 26 ) and the APEX protocol ( 39 ) provide further help. APEX is also implemented in a free software tool developed by John Braisted and colleagues at the J. Craig Venter Institute, Rockville, MD ( 38 ) . The software, called the APEX Quantitative Proteomics Tool, is freely available from http://pfgrc.jcvi.org/index.php/bioinformatics/apex.html . We recommend the user to try this Javabased tool. It essentially involves the same steps as described here, but does not require the use of Perl scripts. Using the Perl scripts (and modifying these) allows the user to include further developments such as those described in Note 10 .
